Public Citizen Pushes for Boxed Warning on Type 2 Diabetes Drugs

By Sam | July 6, 2020

Public Citizen has petitioned the FDA to require a black box warning for sodium-glucose cotransporter-2 (SGLT2) inhibitors used off-label for treatment of type 1 diabetes.
Source: Drug GMP Report

Posted in Drug GMP Report